Black Bird Biotech

Black Bird Biotech Current Liabilities

Current Liabilities of Black Bird Biotech (BBBT) as of Nov 14, 2026.

Current Liabilities

-USD

Last updated:

Current Liabilities of Black Bird Biotech is 2026 - USD. Current Liabilities of Black Bird Biotech was 2025 884,678.00 USD. It decreases by % lower compared to the previous year.

The Black Bird Biotech Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2015
693,891.00 USD
Jan 1, 2016
802,217.00 USD
Jan 1, 2017
899,291.00 USD
Jan 1, 2018
1.02 M USD
Jan 1, 2019
267,195.00 USD
Jan 1, 2020
98,541.00 USD
Jan 1, 2021
103,994.00 USD
Jan 1, 2022
884,678.00 USD
The Black Bird Biotech Current Liabilities history
YEARCurrent LiabilitiesYoY
884,678.00USD+750.70%
103,994.00USD+5.53%
98,541.00USD-63.12%
267,195.00USD-73.90%
1.02 MUSD+13.82%
899,291.00USD+12.10%
802,217.00USD+15.61%
693,891.00USD+657.57%
91,594.00USD+24.40%
73,631.00USD-81.69%
402,121.00USD+840.15%
42,772.00USD+152.79%
16,920.00USD-83.08%
100,000.00USD+22,122.22%
450.00USD+350.00%
100.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Black Bird Biotech Stock analysis

What does Black Bird Biotech do? Black Bird Biotech, Inc. generates revenue through the manufacture and sale of cannabidiol (CBD) products under its brands MiteXstream, Grizzly Creek Naturals, and Black Bird American Hemp. The company's subsidiary Black Bird Potentials, Inc. (BB Potentials) produces CBD oils, gummies, pet treats, and personal care products under the Grizzly Creek Naturals brand. Big Sky American Dist., LLC (Big Sky American) distributes Grizzly Creek Naturals products alongside other consumer retail items in Western Montana, serving retail customers in that region. The firm's product portfolio targets consumers seeking CBD-infused wellness and personal care solutions across multiple segments. BB Potentials focuses on CBD product lines including oils, gummies, and pet treats, while Black Bird American Hemp likely caters to broader hemp-based consumer markets. Big Sky American acts as a distributor for Grizzly Creek Naturals, expanding market reach in Western Montana without direct sales to end consumers. The company's revenue streams are derived from B2B distribution agreements with Big Sky American and direct sales of its branded CBD products to end consumers through various channels. Black Bird Biotech's business model relies on a dual approach: manufacturing and branding CBD products for direct consumer sales, and partnering with Big Sky American for regional distribution. The Grizzly Creek Naturals brand is central to both direct sales and distribution, with products available in retail settings across Western Montana. The company's subsidiaries, BB Potentials and Big Sky American, facilitate production and distribution, ensuring market penetration in key geographic areas. Black Bird Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Black Bird Biotech stock

On Eulerpool you can find the complete historical development of Current Liabilities Black Bird Biotech since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Black Bird Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Black Bird Biotech

All Key Metrics — Black Bird Biotech